Microbot Medical Inc.
MBOT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $17 | $22 | $53 |
| - Cash | $3 | $2 | $2 | $13 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $15 | $14 | $20 | $40 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$11 | -$13 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$11 | -$13 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.73 | -1.05 | -1.81 | -1.59 |
| % Growth | 30.5% | 42% | -13.8% | – |
| Operating Cash Flow | -$9 | -$9 | -$12 | -$9 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$9 | -$12 | -$9 |